Synergy CHC Corp

Synergy CHC Corp(SNYR)の株式分析

$0.091

-0.061 (-67.02%)終値時点

Loading chart…
高値
0.157
始値
0.137
出来高加重平均価格
0.11
出来高
70.12M
時価総額
—
安値
0.091
売買代金
7.90M
EV/EBITDA(TTM)
-8.03

Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.

synergychc.com

AI分析 of Synergy CHC Corp (SNYR)

売り

Synergy CHC Corp is not a good buy right now due to its poor financial performance and significant losses. The current price is $0.10, and the company reported a staggering net loss of $14.82 million in Q4 2025, which raises serious concerns about its sustainability. Additionally, the forward P/E ratio is 0.5347, indicating that the market is not optimistic about future earnings, and the stock has declined 94.65% year-to-date, reflecting a lack of investor confidence.

バリュエーション指標

Synergy CHC Corp(SNYR)の現在の予想PERは1.83で、5年平均は1.51です。

予想PER

適正
5年平均 P/E
1.51
現在のP/E
1.83
割高
3.81
割安
-0.79

予想EV/EBITDA

割安
5年平均 EV/EBITDA
1.43
現在のEV/EBITDA
-8.03
割高
6.47
割安
-3.62

予想PSR

割安
5年平均 P/S
0.34
現在のP/S
0.04
割高
0.59
割安
0.09

イベントタイムライン

2026-08-21 (ET)

09:00:00

Synergy CHC Receives Compliance Notice from Nasdaq

2026-05-15 (ET)

17:10:00

Synergy CHC Files to Sell 101.71M Shares of Common Stock

2026-04-01 (ET)

09:20:00

Company Q4 Revenue Falls to $6.07M

2026-01-27 (ET)

08:10:00

Synergy CHC Expands FOCUSfactor Product Line in Canada

2025-12-16 (ET)

08:10:00

Synergy CHC Appoints Pedro Colmenares as Sales & Marketing Director for Mexico & Latin America

ニュース

SNYR のよくある質問 — Alphio AI が回答

Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications. It operates in the Healthcare sector.

Synergy CHC Corp is not a good buy right now due to its poor financial performance and significant losses. The current price is $0.10, and the company reported a staggering net loss of $14.82 million in Q4 2025, which raises serious concerns about its sustainability. Additionally, the forward P/E ratio is 0.5347, indicating that the market is not optimistic about future earnings, and the stock has declined 94.65% year-to-date, reflecting a lack of investor confidence.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める